Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peritoneal molecular environment, adhesion formation and clinical implication.

Nasser Chegini1

  • 1Division of Reproductive Endocrinology and Infertility, Institute for Wound Research, Department of Obstetrics and Gynecology, University of Florida, Gainesville, FL 32610, USA. cheginin@obgyn.ufl.edu

Frontiers in Bioscience : a Journal and Virtual Library
|March 19, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Retraction notice to Doxycycline Alters the Expression of Matrix Metalloproteases in the Endometrial Cells Exposed to Ovarian Steroids and Pro-inflammatory Cytokine JRI 73/2 (April 2017);118-129.

Journal of reproductive immunology·2018
Same author

miR-200c is aberrantly expressed in leiomyomas in an ethnic-dependent manner and targets ZEBs, VEGFA, TIMP2, and FBLN5.

Endocrine-related cancer·2012
Same author

Endometrial miR-200c is altered during transformation into cancerous states and targets the expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5.

Reproductive sciences (Thousand Oaks, Calif.)·2012
Same author

miR-93/106b and their host gene, MCM7, are differentially expressed in leiomyomas and functionally target F3 and IL-8.

Molecular endocrinology (Baltimore, Md.)·2012
Same author

Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3.

The Journal of clinical endocrinology and metabolism·2012
Same author

Uterine microRNA signature and consequence of their dysregulation in uterine disorders.

Animal reproduction·2012

Peritoneal adhesions cause pelvic pain, bowel obstruction, and infertility. Understanding the molecular basis of adhesion formation is crucial for developing effective prevention strategies beyond empirical methods.

Area of Science:

  • Molecular Biology
  • Immunology
  • Surgical Pathology

Background:

  • Peritoneal adhesions are a significant complication following abdominal surgery, infection, inflammation, or ischemia.
  • Adhesions are a leading cause of pelvic pain, bowel obstruction, and infertility, yet the mechanisms of their formation and site specificity remain unknown.
  • The predisposition to adhesion formation varies significantly among patients and even between surgical sites within the same patient.

Purpose of the Study:

  • To review the clinical implications of peritoneal adhesions.
  • To highlight key molecules regulating peritoneal wound healing and adhesion formation.
  • To discuss novel strategies for preventing adhesions.

Main Methods:

  • Review of current literature on peritoneal adhesion formation.

Related Experiment Videos

  • Identification and discussion of key molecular regulators including growth factors, cytokines, chemokines, proteases, and extracellular matrix components.
  • Exploration of potential therapeutic applications and targeted delivery systems.

    • Main Results:

    • Adhesion formation involves complex molecular processes including inflammation, fibrinolysis, angiogenesis, and tissue remodeling.
    • Several biologically active molecules are implicated in regulating these processes.
    • Current understanding of their specific roles in peritoneal adhesion formation is largely speculative.

    Conclusions:

    • Understanding the molecular mechanisms of peritoneal adhesion is essential for developing targeted prevention strategies.
    • Novel approaches involving modulation of inflammatory/immune responses, gene delivery, and advanced biomaterials show promise.
    • Insights into peritoneal biology can also benefit management of endometriosis and peritoneal malignancies.